Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.

Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.

Item
http://www.wikidata.org/entity/Q40775150
The Diagnosis and Treatment of Optic NeuritisTreatment of Neuromyelitis Optica Spectrum Disorder: Acute, Preventive, and Symptomatic.Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel(®)Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse.Outcome of MS relapses in the era of disease-modifying therapy.Glucocorticoid receptors: finding the middle ground.An In Situ Gelling Drug Delivery System for Improved Recovery after Spinal Cord Injury.The Ocular Manifestations of Drugs Used to Treat Multiple Sclerosis.Corticosteroids in the management of acute multiple sclerosis exacerbations.Oral and intravenous steroids for multiple sclerosis relapse: a systematic review and meta-analysis.Reducing costs while enhancing quality of care in MS.Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials.GSH-PEGylated liposomal methylprednisolone in comparison to free methylprednisolone: slow release characteristics and prolonged lymphocyte depression in a first-in-human study.Diagnosis and treatment of latent tuberculosis in patients with multiple sclerosis, expert consensus. On behalf of the Colombian Association of Neurology, Committee of Multiple Sclerosis.Oral rather than intravenous corticosteroids should be used to treat MS relapses - Commentary.Care of persons with MS in clinical practice: Management by majority.Visual outcome is similar in optic neuritis patients treated with oral and i.v. high-dose methylprednisolone: a retrospective study on 56 patients
P2860

Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.

Item
http://www.wikidata.org/entity/Q40775150
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Oral versus intravenous high-d ...... -blind, non-inferiority trial.
@en
type
label
Oral versus intravenous high-d ...... -blind, non-inferiority trial.
@en
prefLabel
Oral versus intravenous high-d ...... -blind, non-inferiority trial.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Oral versus intravenous high-d ...... -blind, non-inferiority trial.
@en
P2093
P304
P31
P356
10.1016/S0140-6736(15)61137-0
P407
P433
P478
P577
P698
P921